ArticleBMJ open2022

Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain.

Chelsea K Pike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.